Yulianna Laurencin, PharmD Candidate

home / authors / yulianna-laurencin-pharmd-candidate

Articles

Blood samples -- Image credit: Felipe Caparrós | stock.adobe.com

The Blood Detective: Tackling Medication-Induced Hematological Disorders

Nana Kwesi Owusu-Boakye, PharmD Candidate;Chinonso Paul, PharmD Candidate, MBA Candidate;Taylor Roberson, PharmD Candidate;Shreya Kumar, PharmD Candidate;Yulianna Laurencin, PharmD Candidate;Sara Rogers, PharmD, BCPS
February 14th 2024

These disorders can be fatal, making pharmacists’ role in detection crucial.

Read More

Woman with menstrual pain -- Image credit: Kaspars Grinvalds | stock.adobe.com

Give Your Patients Options for Managing Menstrual Pain

Omolara Falade, PharmD Candidate;Janet John, PharmD Candidate;Yulianna Laurencin, PharmD Candidate;Chinonso Paul, PharmD Candidate, MBA Candidate;Sara Rogers, PharmD, BCPS
January 31st 2024

Recommendations range from contraceptives to heat therapy to holistic use of spices.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD